FDA Clearance Tracker · P080025-S148
InterStim® Sacral Nerve Stimulation Therapy System / Bowel Control
Last checked: Nov 20, 2026Latest source record: Feb 7, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2018
Approved
Time to decision
170 days
Received Aug 21, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080025-S148
- Device name
- InterStim® Sacral Nerve Stimulation Therapy System / Bowel Control
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Aug 21, 2017
- Decided
- Feb 7, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P080025
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval for labeling updates to incorporate 5 year data from the InSite Post-Approval Study (Single Tined Lead (protocol 1634).
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.